These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Melanocortin receptor agonists suppress experimental autoimmune uveitis. Ng TF; Dawit K; Taylor AW Exp Eye Res; 2022 May; 218():108986. PubMed ID: 35196505 [TBL] [Abstract][Full Text] [Related]
5. Melanocortin-5 Receptor: Pharmacology and Its Regulation of Energy Metabolism. Ji LQ; Hong Y; Tao YX Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955857 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the sea bass melanocortin 5 receptor: a putative role in hepatic lipid metabolism. Sánchez E; Rubio VC; Cerdá-Reverter JM J Exp Biol; 2009 Dec; 212(Pt 23):3901-10. PubMed ID: 19915133 [TBL] [Abstract][Full Text] [Related]
18. New ligands for melanocortin receptors. Kaelin CB; Candille SI; Yu B; Jackson P; Thompson DA; Nix MA; Binkley J; Millhauser GL; Barsh GS Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S19-27. PubMed ID: 19136986 [TBL] [Abstract][Full Text] [Related]
19. Harnessing the melanocortin system in the control of food intake and glucose homeostasis. Swan P; Johnson B; le Roux CW; Miras AD Peptides; 2024 Sep; 179():171255. PubMed ID: 38834138 [TBL] [Abstract][Full Text] [Related]
20. Melanocortin receptors as targets in the treatment of obesity. Lam DD; Farooqi IS; Heisler LK Curr Top Med Chem; 2007; 7(11):1085-1097. PubMed ID: 17584129 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]